QBie™ Spotlight: Lexagene Holdings Inc. (OTCQB: LXXGF)

QBie™ Spotlight joins Dr. Jack Regan, Founder and CEO of Lexagene Holdings Inc. (OTCQB: LXXGF), to discuss one of the OTCQB’s newest additions. LXXGF joined the OTCQB on February 21, 2017.  

What does Lexagene do?

Dr. Jack Regan (CEO – OTCQB: LXXGF):  “LexaGene is in the business of detecting pathogens. We build automated instruments so that the people working on the front-lines can perform tests that normally would require a highly skilled microbiologist. Our instrument can screen samples for 22 pathogens and return results in ~ 1 hour. It also allows end-users to customize their screens, which is a feature not available in any other automated instrument. We can even detect the presence of antibiotic resistance and virulence genes. We anticipate selling our technology into markets where speed and ease of use are important, namely: medical clinics, veterinary hospitals, food packaging plants, municipalities that monitor water quality, and even aquaculture and poultry farms where disease spread can cause total crop loss.”   



What is the next big goal LXXGF is trying to accomplish/what should we keep an eye out for? 


Jack Regan: “We anticipate finishing our alpha prototype in November, 2017. This instrument will be able to process six samples at a time, where each sample is concentrated, the genetic material is purified, and 22 pathogen tests are performed.


Why did you join the OTCQB/go public?

Jack Regan: “We joined the OTCQB since we felt like the company’s technology and mission statement – of providing instruments for customized pathogen detection – resonates with so many people, and being public allows us to include anyone who wants to be a part of something so exciting and disruptive.”  

How can members of the microcap community help you?

Jack Regan: “Greater exposure to the US microcap and biotech investors

Learn more about Lexagene Holdings Inc. (OTCQB: LXXGF) at: www.lexagene.com

About QBie™ Spotlight:

QBie™ Spotlight is a virtual “welcome interview” for new OTCQB companies. QBie™ Spotlight helps issuers that are new to the OTCQB connect with microcap industry professionals! Learn more about the QBie™ Spotlight HERE.

Disclaimer/Forward Looking Statements: 

This Website and its contents are not to be construed, under any circumstances, as an offer to sell or a solicitation to buy or effect transactions in any securities. No investment advice is provided or should be construed to be provided herein. This Website and its owners, employees and affiliates are not, nor do any of them claim to be, registered broker-dealers or registered investment advisors. This Website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Such forward-looking statements of or concerning the companies mentioned herein are subject to numerous uncertainties and risk factors, including uncertainties and risk factors that may not be set forth herein, which could cause actual results to differ materially from those stated herein. Accordingly, user of this Website are cautioned not to place undue reliance on such forward-looking statements. This Website undertakes no obligation to update any forward-looking statements that may be contained herein.




QBie™ Spotlight



OTC Markets


Lexagene Holdings



Jack Regan



Leave a Reply